SB 5378 expands financial assistance for small school districts and small businesses under Washington’s paid family and medical leave program. It allows eligible employers (including second-class school districts and businesses with 50-150 employees) to receive up to $3,000 for hiring temporary workers during employee leave or up to $1,000 to cover extra wage costs from leave. Grants are limited to 10 per year per employer, require documentation linking costs to leave, and apply only to employees using the program. Small businesses (under 50 employees) receiving grants face three years of full premium assessments under the program.
HB 1971 requires health plans to provide reimbursement for a 12-month refill of covered prescription hormone therapy, obtained at one time, for their enrollees. This aims to increase access to these medications for patients of all ages. Starting January 1, 2026, health plans must comply, unless the enrollee requests a smaller supply, the provider instructs a smaller supply, or the therapy is a controlled substance. The 12-month supply applies to medications that can be safely stored at room temperature, while controlled substances must be covered for the maximum refill allowed by law. Prescription hormone therapy is defined as FDA-approved drugs that medically adjust hormone levels, excluding certain glucagon-like peptide-1 medications.
HB 1466 increases the biennial funding amount used to replace state general fund payments for Medicaid hospital services, raising it from $452 million to $527 million for the 2025-2027 fiscal biennium, with a subsequent rise to $552 million per biennium starting in 2027. This funding directly affects hospitals and managed care organizations receiving Medicaid payments, as it replaces state general fund contributions while maintaining payment levels at 2022 rates (adjusted for enrollment). The bill specifies that $160 million annually must fund postacute hospital transitions and allocates $2 million for psychiatry residency programs and $4.1 million for family medicine residency slots at the University of Washington. It also ensures funds are used exclusively for Medicaid hospital services, administrative costs, and federal compliance, with no new programs created.
HB 1664 requires Washington's long-term care ombuds program to submit annual funding recommendations by September 1 each year. The recommendations must ensure funding achieves a 1:2,000 ombudsman-to-resident ratio (per Institute of Medicine guidelines), account for projected facility bed growth, inflation, and administrative needs. This directly affects residents in licensed long-term care facilities by mandating sufficient resources to investigate complaints and protect their rights. The bill shifts the program from current underfunding to a structured, annually updated funding process.
SB 5477 updates Washington's mental health parity law to improve access to mental health and substance use disorder services by requiring health insurers to cover medically necessary care based on established clinical standards. The bill defines "medically necessary" care as services aligned with evidence-based guidelines from recognized medical associations and eliminates previous exclusions for substance use disorder treatments (effective 2026) and certain diagnostic codes. It mandates consistent coverage rules for both mental health and substance use disorders, removes administrative barriers for providers joining insurance networks, and repeals outdated provisions that limited coverage. This directly affects health insurers, healthcare providers, and patients seeking covered mental health and substance use treatment services in Washington.
HB 1868 creates a state matching grant program to help critical access hospitals hire licensed athletic trainers who provide free services to students in local school districts. Hospitals can receive up to $60,000 in state funds, matching their own contributions, to cover trainer salaries, medical supplies, equipment, and program promotion. To qualify, hospitals must demonstrate school district need, detail how funds will be used, and prove they can match the state grant amount. The program requires hospitals to wait 12 months before reapplying and mandates a 2026 legislative report on implementation. This directly affects critical access hospitals and the school districts they serve.
HB 1725 requires health plans in Washington to streamline access to biosimilar medicines (safe, effective, lower-cost alternatives to brand-name biologics) by mandating clear exception processes for coverage denials. It directly affects patients, doctors, and health insurance companies by requiring health plans to: (1) post plain-language exception rules online, (2) approve exceptions meeting specific medical criteria (like drug ineffectiveness or adverse reactions), and (3) follow strict timelines (1-3 business days) for urgent/non-urgent requests. The bill eliminates barriers by ensuring health plans must cover biosimilars when clinical evidence supports them, with automatic approval if deadlines are missed. This aims to reduce prescription drug costs without altering drug approval standards.
HB 1076 establishes a structured process for Washington State’s health technology assessment program, directly affecting state health programs (like Medicaid) that decide which medical technologies qualify for coverage. The bill requires the state to systematically review health technologies prioritized based on Medicare coverage, expert guidelines, safety concerns, high costs, or significant usage variations, with up to eight reviews annually. Key provisions mandate evidence-based assessments of safety, efficacy, and cost-effectiveness - considering patient input and unique impacts on populations (e.g., age, disability) - and require decisions within 180 days of submission. The program must align with federal Medicare decisions unless new evidence supports a different conclusion, ensuring transparency through public comment and written explanations for denied requests.
HB 1566 requires health insurance companies in Washington to improve transparency in prior authorization decisions for medical treatments and drugs. It sets strict time limits: insurers must decide on electronic standard requests within 3 days and expedited requests within 1 day, with clear communication if more information is needed. The bill mandates that insurers provide evidence-based clinical criteria (updated annually to address health disparities) and include provider credentials when denying requests. It also restricts insurers from changing prior authorization policies more than quarterly, requiring 45 days' notice to providers for most updates. This directly affects insurers, healthcare providers, and patients receiving covered care.
SB 5126 creates a statewide network to coordinate school-based mental and behavioral health services for Washington K-12 students. It directs the Office of the Superintendent of Public Instruction (OSPI) to lead strategic planning, streamline access to resources, and establish regional programs through Educational Service Districts. The bill requires schools to implement evidence-based screening, prevention, and intervention services - including substance use education - and coordinate with community partners. This directly affects all public schools, students, and local education agencies by standardizing support systems currently fragmented across multiple state agencies.
